Peptide RX Prediction
2fXcg8jZ7zByFhhdwPz7oyTjEpC7AsxdfbaAntsgAgzt
$0.000595
FDV $594,918
2fXcg8jZ7zByFhhdwPz7oyTjEpC7AsxdfbaAntsgAgztChain:SolanaHolders:1,032Market cap:$594,918More tokens on Solana
Continue in chat
Ask Unhosted AI about PEPTIDE
$594,918
$69,278
1,032
27
Very High
AI Executive Summary
Peptide RX (PEPTIDE) is a Solana-based token trading at $0.000595 with a fully diluted valuation of ~$595K. The token launched recently (holders were flat at 181 from March 31 through April 21, then surged to 1,119 by April 28), suggesting a very young project that experienced a rapid growth event. The 24h price action shows a -28% decline from recent highs near $0.00123, with heavy sell pressure (75.2% sell volume) dominating. Liquidity is thin at $69.28K, and the token trades on PumpSwap. The project describes itself as focused on peptide research and enhancement.
Price Prediction
Short term
Price is in a clear short-term downtrend, falling from a 24h high near $0.001226 to the current $0.000595 — a drop of ~51% from peak. Sell pressure is overwhelming at 75.2% of volume. The 5-minute change of -3.69% confirms continued selling momentum. A short-term bounce is possible given the 6h gain of +16.79%, but the dominant trend remains bearish.
Resistance: $0.000626 (candle [1] and [2] highs), $0.000660 (candle [10] high), $0.000801 (candle [11] high)
Medium term
The token is in a medium-term downtrend from its all-time high region near $0.001226. Holder count declined -83 on April 29 after peaking at 1,119 on April 28, suggesting the initial hype wave is fading. With thin liquidity, concentrated whale holdings, and multiple snipers having already taken large profits (532%, 512%, 406% realized PnL), sustained upward price action would require significant new demand that is not currently evident.
Catalysts
- New exchange listings or DEX liquidity additions
- Viral social media campaign or influencer promotion
- Broader Solana memecoin market rally
- Project utility announcements related to peptide research narrative
Bullish factors
- 6h price change of +16.79% shows short-term buying interest
- Holder base grew 82% over 30 days (from 181 to 1,032)
- Verified contract and mutable=false metadata reduce some rug risk
- 1,778 buy transactions in 24h shows active participation
Bearish factors
- 24h price decline of -28.1% with 75.2% sell volume dominance
- Multiple high-profit snipers (CVxUKFrWDYkE3gsZP9gyVmLD6XkXykk2ukKhAfNrJev8 +532%, BGzLYcFcUZkW5GPZZAYK4Jxyf1W7aigyHQbvmKsQeeuq +513%) likely still holding remaining positions
- Holder count dropped -83 (-8%) on April 29 alone
- Liquidity of $69.28K is extremely thin for a $595K FDV token
- Top 10 holders control 32.58% of supply; top 100 control 82.87%
Deep Analysis
Token Info
Key Risks
Smart Money & Sniper Analysis
20 snipers were identified in the first 1,000 blocks. Sniper PnL is highly mixed: 8 snipers show positive realized PnL ranging from +6.1% to +532.4% (CVxUKFrWDYkE3gsZP9gyVmLD6XkXykk2ukKhAfNrJev8 +532%, BGzLYcFcUZkW5GPZZAYK4Jxyf1W7aigyHQbvmKsQeeuq +513%, CkUZV387xnoGpF7wC2moMa6mPmAgCvTT4pWgzq4M9fCD +406%, HpBQZoprdtWC9MFZoLEKSi1PvSFhGFYDJt9ryxooUHCT +344%), while 7 snipers are in loss (-1.9% to -59.8%). The high-profit snipers have collectively sold thousands of dollars worth of tokens, suggesting significant early distribution. Sniper entry prices are unknown, limiting precise concentration calculations. Estimated sniper concentration is low (~2%) given unknown balances, but their realized profits indicate they entered at very low prices and have been distributing into retail demand.
AI-generated insight. Not financial advice.
Sniper details
20 snipers identified in first 1,000 blocks; exact balances unknown but several have sold significant USD amounts ($5,502, $7,236, $2,661, $1,735, $1,157)
Mixed to negative — while some early buyers (snipers) booked exceptional profits (100–532%), the majority of the 20 snipers show either losses or minimal gains, and the largest sellers have already exited significant positions. This suggests the smart money that profited has largely distributed, leaving later buyers holding depreciating positions.
Frequently Asked Questions
What is the price prediction for Peptide RX (PEPTIDE)?
Price is in a clear short-term downtrend, falling from a 24h high near $0.001226 to the current $0.000595 — a drop of ~51% from peak. Sell pressure is overwhelming at 75.2% of volume. The 5-minute change of -3.69% confirms continued selling momentum. A short-term bounce is possible given the 6h gain of +16.79%, but the dominant trend remains bearish. Short-term outlook is bearish (24–72 hours), with a target range of $0.000404 to $0.000660.
Is PEPTIDE a safe investment on Solana?
Overall risk is rated very_high with a risk score of 8.5/100. Suitable only for highly risk-tolerant, experienced crypto traders who understand memecoin dynamics and can afford to lose their entire investment. Not suitable for conservative investors, those seeking stable returns, or anyone investing more than they can afford to lose completely. Position sizing should be minimal (1–2% of portfolio maximum) if participating at all.
How are PEPTIDE holders trending?
Peptide RX currently has 1,032 holders and is growing (24h: -6.6, 7d: 72, 30d: 82). The holder history reveals a dormant token: from March 31 to April 21, holders were completely flat at 181 for 22 consecutive days — zero net change. This is highly unusual and may indicate the token was pre-launched or held by insiders before a coordinated launch event. The explosive growth began April 22 (+109 holders, +38%) and peaked April 28 (+628 holders, +56% in a single day — the largest single-day gain). April 29 saw a reversal of -83 holders (-8%), and the current 24h shows -68 (-6.6%), suggesting the holder base is now contracting as early buyers exit. Growth is decelerating and reversing, not accelerating.
What does sniper activity look like for PEPTIDE?
Snipers hold roughly 2.00% of supply with PnL state "mixed" and sell-through rate "moderate". Profit-taking risk: high.
What are the key risks of holding PEPTIDE?
Extreme sell pressure: 75.2% of 24h volume is sells with 3x more sell volume than buy volume • Thin liquidity ($69.28K) makes price highly manipulable and creates severe exit risk • Holder count declining: -83 on April 29, -68 in last 24h — community is shrinking post-pump
Track PEPTIDE